All members have the option of attending our various HTC-centric events which include:
Date: Thursday, November 21, 2024 Time: 2:00pm - 3:00pm ET Title: Health Equity Description: Please join Takeda for a webinar on Health Equity and how Takeda is making progress towards its goal of improving equitable access to treatment and care for all. Anthea will share Takeda's broad strategy, how it relates to bleeding disorders, and Read the full article...
Date: Wednesday, December 4, 2024 Time: 12:00pm - 1:00pm ET Topic: Real World Surgical Experiences with Altuviiio Description: This program will focus on sharing real-world experiences with Altuviiio, especially within a surgical context. We’ll kick things off with an introduction to Altuviiio, followed by some in-depth discussions on surgical experiences. We’ll wrap Read the full article...
Date: Wednesday, December 11, 2024 Time: 1:00pm - 2:00pm ET TOPIC: Learn about HEMGENIX from the patient perspective OBJECTIVE: Michael will share his personal experience after receiving HEMGENIX RECOMMENDED AUDIENCE: HTC providers, social workers, administration and support staff SPEAKER: Michael - Common Factors Advocate Hemophilia B My Life at a Glance Read the full article...
Date: Tuesday, December 17, 2024 Time: 3:00pm - 4:00pm ET TOPIC: HYMPAVZI: An anti-tissue factor pathway inhibitor OBJECTIVE: To educate attendees on the novel mechanism of action of HYMPAVZI, the Ph3 clinical trial results and indicated dosage and administration. INTENDED AUDIENCE: HCP SPEAKER: Dr. Jennifer Schumacher, PhD, Senior Medical Director, Hemophilia Read the full article...
Date: Wednesday, December 18, 2024 Time: 1:00pm - 2:00pm ET Title: Unmet Needs in Current Hemophilia Care: From Burdens to Breakthroughs Description and Session Objectives: To provide a clinical overview of the cost and treatment burden across all hemophilia types, the experience with current therapy, and unmet needs that may be Read the full article...
Date: January 22 - 24, 2025 Location: The Westin San Diego Gaslamp Quarter, San Diego, CA 92101 Hemophilia Alliance is proud to announce the 4th Annual Pharmacists CE Conference. The conference is designed specifically for Hemophilia Alliance Member HTC pharmacists with direct responsibility for 340B HTC dispensations. There will be 40 spaces available for the Read the full article...
Date: Wednesday, February 19, 2025 Time: 1:00pm - 2:00pm ET TITLE: ROCTAVIAN: Improving Patient Outcomes - Latest Data & Support Initiatives OBJECTIVE: Join us for a webinar on ROCTAVIAN (valoctocogene roxaparvovec), the groundbreaking gene therapy for severe hemophilia A. This webinar will delve into the latest clinical data updates, showcasing the long-term Read the full article...
Date: February 26 - 28, 2025 Location: Austin, TX Please contact Jeff Amond with any questions regarding this registration at amond@hemoalliance.org or 608-206-3132.
Date: March 9 - 11, 2025 Location: Salt Lake City, Utah Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
Date: Wednesday, March 19th, 2025 Time: 12:00pm - 1:00pm ET WEBINAR TOPIC: Updates from Washington: Administration and Congressional Actions OBJECTIVE: The current status of government funding for fiscal year 2025. The potential impact of the new Administration’s early actions, including Executive Orders, reduction in agency staffing, changes to the regulatory process and how this may Read the full article...
Date: Thursday, March 20th, 2025 Time: 2:00pm - 3:00pm ET TITLE: Takeda FVIII Portfolio OBJECTIVE: Please join Takeda leadership to review Takeda FVIII Products & Resources Available. INTENDED AUDIENCE: All HTC staff SPEAKER: Anthea Cherednichenko, VP US Hematology Franchise Head Anthea leads the sales and marketing teams for Takeda’s Hematology portfolio. Anthea Read the full article...
Date: Thursday, April 3rd, 2025 Time: 2:00pm - 3:00pm ET WEBINAR TOPIC: Alhemo (concizumab-mtci): A new option for patients living with hemophilia A or B with inhibitors OBJECTIVE: To provide a prescribing information overview of the recently FDA approved medication, Alhemo (concizumab-mtci), for patients living with hemophilia A or B with Read the full article...
Date: April 17th, 2025 Click here for info.
Date: April 23rd - 25th Location: Dubai
Date: April 27 - 29, 2025 Location: Orlando, FL Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
Date: April 29 - May 1, 2025 Location: Orlando, FL Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
Date: Tuesday, May 6th, 2025 Time: 2:00pm - 3:00pm ET WEBINAR TOPIC: Complications and challenges associated with hemophilia and a rebalancing approach with HYMPAVZI™ (marstacimab-hncq) OBJECTIVES: Educate attendees on complications and challenges associated with hemophilia, the novel mechanism of action of HYMPAVZI, the BASIS Ph3 clinical trial results and dosage and Read the full article...
Date: Wednesday, May 7th, 2025 Time: 1:00pm - 2:00pm ET WEBINAR TOPIC: Exploring data and expert perspectives on Qfitlia™ (fitusiran) OBJECTIVE: During this program, we will explore data and expert perspectives on Qfitlia™ (fitusiran), a newly approved prophylactic treatment for patients with hemophilia A and B, with or without inhibitors. SPEAKER: Vanessa Read the full article...
Date: Tuesday, May 13th, 2025 Time: 1:00pm - 2:00pm ET WEBINAR TOPIC: A Collaborative Journey - ROCTAVIAN Patient & Provider Perspectives OBJECTIVE: Join us for an insightful webinar exploring the real-world experiences of patients and providers with ROCTAVIAN. Hear firsthand accounts of the treatment journey, from initial consultations and administration to outcomes Read the full article...
Date: May 14 - 16, 2025 Location: Phoenix, AZ Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
